Use of RNA-protein complexes for genome editing in non-albicans Candida species

mSphere

Volumn 2, Issue 3, 2017, Pages

  Grahl, Nora ^a,b   Demers, Elora G ^a   Crocker, Alex W ^a   Hogan, Deborah A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

Auris; Candida; CRISPR; Genome editing; Glabrata; Lusitaniae; Molecular methods

Indexed keywords

EID: 85027462885     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00218-17     Document Type: Article

References (32)

1. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816-821. https://doi.org/10.1126/science .1225829
2. Sternberg SH, Doudna JA. 2015. Expanding the biologist's toolkit with CRISPR-Cas9. Mol Cell 58:568-574. https://doi.org/10.1016/j.molcel.2015 .02.032
3. Sander JD, Joung JK. 2014. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 32:347-355. https://doi.org/10 .1038/nbt.2842
4. Kick L, Kirchner M, Schneider S. 2017. CRISPR-Cas9: from a bacterial immune system to genome-edited human cells in clinical trials. Bioengineered 8:280-286. https://doi.org/10.1080/21655979.2017 .1299834
5. Mitchell AP. 2017. Location, location, location: use of CRISPR-Cas9 for genome editing in human pathogenic fungi. PLoS Pathog 13:e1006209. https://doi.org/10.1371/journal.ppat.1006209
6. Krappmann S. 2017. CRISPR-Cas9, the new kid on the block of fungal molecular biology. Med Mycol 55:16-23. https://doi.org/10.1093/mmy/ myw097
7. Vyas VK, Barrasa MI, Fink GR. 2015. A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families. Sci Adv 1:e1500248. https://doi.org/10.1126/sciadv.1500248
8. Min K, Ichikawa Y, Woolford CA, Mitchell AP. 2016. Candida albicans gene deletion with a transient CRISPR-Cas9 system. mSphere 1:e00130-16. https://doi.org/10.1128/mSphere.00130-16
9. Norton EL, Sherwood RK, Bennett RJ. 2017. Development of a CRISPRCas9 system for efficient genome editing of Candida lusitaniae. mSphere 2:e00217-17. https://doi.org/10.1128/mSphere.00217-17
10. Enkler L, Richer D, Marchand AL, Ferrandon D, Jossinet F. 2016. Genome engineering in the yeast pathogen Candida glabrata using the CRISPRCas9 system. Sci Rep 6:35766. https://doi.org/10.1038/srep35766
11. Ramakrishna S, Kwaku Dad AB, Beloor J, Gopalappa R, Lee SK, Kim H. 2014. Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. Genome Res 24:1020-1027. https://doi .org/10.1101/gr.171264.113
12. Woo JW, Kim J, Kwon SI, Corvalán C, Cho SW, Kim H, Kim SG, Kim ST, Choe S, Kim JS. 2015. DNA-free genome editing in plants with preassembled CRISPR-Cas9 ribonucleoproteins. Nat Biotechnol 33:1162-1164. https://doi.org/10.1038/nbt.3389
13. Shin SE, Lim JM, Koh HG, Kim EK, Kang NK, Jeon S, Kwon S, Shin WS, Lee B, Hwangbo K, Kim J, Ye SH, Yun JY, Seo H, Oh HM, Kim KJ, Kim JS, Jeong WJ, Chang YK, Jeong BR. 2016. CRISPR/Cas9-induced knockout and knock-in mutations in Chlamydomonas reinhardtii. Sci Rep 6:27810. https://doi.org/10.1038/srep27810
14. Pohl C, Kiel JA, Driessen AJ, Bovenberg RA, Nygård Y. 2016. CRISPR/Cas9 based genome editing of Penicillium chrysogenum. ACS Synth Biol 5:754-764. https://doi.org/10.1021/acssynbio.6b00082
15. Lockhart SR, Pham CD, Kuykendall RJ, Bolden CB, Cleveland AA. 2016. Candida lusitaniae MICs to the echinocandins are elevated but FKSmediated resistance is rare. Diagn Microbiol Infect Dis 84:52-54. https:// doi.org/10.1016/j.diagmicrobio.2015.08.012
16. Rodrigues CF, Silva S, Henriques M. 2014. Candida glabrata: a review of its features and resistance. Eur J Clin Microbiol Infect Dis 33:673-688. https://doi.org/10.1007/s10096-013-2009-3
17. Chowdhary A, Voss A, Meis JF. 2016. Multidrug-resistant Candida auris: "new kid on the block" in hospital-associated infections? J Hosp Infect 94:209-212. https://doi.org/10.1016/j.jhin.2016.08.004
18. Asner SA, Giulieri S, Diezi M, Marchetti O, Sanglard D. 2015. Acquired multidrug antifungal resistance in Candida lusitaniae during therapy. Antimicrob Agents Chemother 59:7715-7722. https://doi.org/10.1128/ AAC.02204-15
19. Atkinson BJ, Lewis RE, Kontoyiannis DP. 2008. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med Mycol 46:541-546. https://doi.org/10.1080/13693780801968571
20. Desnos-Ollivier M, Moquet O, Chouaki T, Guérin AM, Dromer F. 2011. Development of echinocandin resistance in Clavispora lusitaniae during caspofungin treatment. J Clin Microbiol 49:2304-2306. https://doi.org/ 10.1128/JCM.00325-11
21. Kaloriti D, Jacobsen M, Yin Z, Patterson M, Tillmann A, Smith DA, Cook E, You T, Grimm MJ, Bohovych I, Grebogi C, Segal BH, Gow NA, Haynes K, Quinn J, Brown AJ. 2014. Mechanisms underlying the exquisite sensitivity of Candida albicans to combinatorial cationic and oxidative stress that enhances the potent fungicidal activity of phagocytes. mBio 5:e01334-14. https://doi.org/10.1128/mBio.01334-14
22. Belenky P, Camacho D, Collins JJ. 2013. Fungicidal drugs induce a common oxidative-damage cellular death pathway. Cell Rep 3:350-358. https://doi.org/10.1016/j.celrep.2012.12.021
23. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403-410. https://doi.org/10.1016/ S0022-2836(05)80360-2
24. Skrzypek MS, Binkley J, Binkley G, Miyasato SR, Simison M, Sherlock G. 2017. The Candida Genome Database (CGD): incorporation of Assembly 22, systematic identifiers and visualization of high throughput sequencing data. Nucleic Acids Res 45:D592-D596. https://doi.org/10.1093/nar/ gkw924
25. Cuéllar-Cruz M, Briones-Martin-del-Campo M, Cañas-Villamar I, Montalvo-Arredondo J, Riego-Ruiz L, Castaño I, De Las Peñas A. 2008. High resistance to oxidative stress in the fungal pathogen Candida glabrata is mediated by a single catalase, Cta1p, and is controlled by the transcription factors Yap1p, Skn7p, Msn2p, and Msn4p. Eukaryot Cell 7:814-825. https://doi.org/10.1128/EC.00011-08
26. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, Thompson JD, Higgins DG. 2011. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539. https://doi.org/10 .1038/msb.2011.75
27. Shen J, Guo W, Köhler JR. 2005. CaNAT1, a heterologous dominant selectable marker for transformation of Candida albicans and other pathogenic Candida species. Infect Immun 73:1239-1242. https://doi .org/10.1128/IAI.73.2.1239-1242.2005
28. Farboud B, Meyer BJ. 2015. Dramatic enhancement of genome editing by CRISPR/Cas9 through improved guide RNA design. Genetics 199: 959-971. https://doi.org/10.1534/genetics.115.175166
29. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, Ryan L, Shackleton J, Trimlett R, Meis JF, Armstrong-James D, Fisher MC. 2016. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 5:35. https://doi .org/10.1186/s13756-016-0132-5
30. Sharma C, Kumar N, Pandey R, Meis JF, Chowdhary A. 2016. Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation. New Microbes New Infect 13:77-82. https://doi.org/10.1016/j.nmni.2016.07.003
31. Sun C, Ouyang M, Cao Z, Ma S, Alqublan H, Sriranganathan N, Wang Y, Lu C. 2014. Electroporation-delivered fluorescent protein biosensors for probing molecular activities in cells without genetic encoding. Chem Commun 50:11536-11539. https://doi.org/10.1039/c4cc04730c
32. De Backer MD, Maes D, Vandoninck S, Logghe M, Contreras R, Luyten WH. 1999. Transformation of Candida albicans by electroporation. Yeast 15: 1609-1618. https://doi.org/10.1002/(SICI)1097-0061(199911) 15:15<1609::AID-YEA485>3.0.CO;2-Y